Scienture Holdings SCNX
NASDAQ SCNX
$0.37 +0.01 (+1.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scienture Holdings (SCNX) Divestments (2023 - 2024)

Scienture Holdings' (SCNX) quarterly Divestments came in at -$774.0 in Q2 2024, down 100.0% quarter-over-quarter from $29.9 million in Q1 2024.

Analysis

Scienture Holdings (SCNX) Divestments (2023 - 2024) Analysis & Trends

Scienture Holdings has disclosed Divestments across 2 years of filings, most recently posting -$774.0 for Q2 2024.

  • In Q2 2024, Divestments changed N/A year-over-year to -$774.0; the TTM figure through Jun 2024 stood at $29.6 million (changed N/A YoY), while the FY2024 annual figure was $29.9 million, up 43445.42% from the prior year.
  • Divestments came in at -$774.0 for Q2 2024 at Scienture Holdings, down from $29.9 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $29.9 million in Q1 2024 to a low of -$351532.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 4.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 52,813.79
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn -
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn -
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn -
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 Scienture Holdings 15.19 Mn 15.19 Mn 335,779.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -774.00
Mar 31, 2024 29.93 Mn
Sep 30, 2023 -351,532.00
Mar 31, 2023 420,269.00